Roger did mention that there was some interest and that they had already been approached with offers regarding the anti-bacterial aspects of the PDC's.

I am not sure what the offer would bring in at this point, but that would be an intersting piece to spin off if it could allow them to focus on the pain market and anticancer applications.

Macer